Oramed Pharmaceuticals Inc.

03.07.2018

ZAG-S&W represented Oramed Pharmaceuticals in an $18.1 million offering of common stock and warrants.

Oramed Pharmaceuticals is a technology company in the field of oral delivery solutions for drugs currently delivered via injection.

Oded Har-Even, Howard Berkenblit and Jeffrey Morlend led the ZAG-S&W team.

 

 

Recent Activity